| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |